172 related articles for article (PubMed ID: 34811725)
1. Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline.
Fox CP; Ahearne MJ; Pettengell R; Dearden C; El-Sharkawi D; Kassam S; Cook L; Cwynarski K; Illidge T; Collins G
Br J Haematol; 2022 Feb; 196(3):507-522. PubMed ID: 34811725
[No Abstract] [Full Text] [Related]
2. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
[TBL] [Abstract][Full Text] [Related]
3. Where do we currently stand with T-cell prolymphocytic leukemia?
Khot A
Leuk Lymphoma; 2019 Mar; 60(3):563-565. PubMed ID: 30668215
[No Abstract] [Full Text] [Related]
4. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).
Dearden CE; Johnson R; Pettengell R; Devereux S; Cwynarski K; Whittaker S; McMillan A;
Br J Haematol; 2011 May; 153(4):451-85. PubMed ID: 21480860
[TBL] [Abstract][Full Text] [Related]
5. Pathobiology of mature T-cell lymphomas.
Cotta CV; Hsi ED
Clin Lymphoma Myeloma; 2008 Dec; 8 Suppl 5():S168-79. PubMed ID: 19073524
[TBL] [Abstract][Full Text] [Related]
6. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
Horwitz SM; Ansell SM; Ai WZ; Barnes J; Barta SK; Choi M; Clemens MW; Dogan A; Greer JP; Halwani A; Haverkos BM; Hoppe RT; Jacobsen E; Jagadeesh D; Kim YH; Lunning MA; Mehta A; Mehta-Shah N; Oki Y; Olsen EA; Pro B; Rajguru SA; Shanbhag S; Shustov A; Sokol L; Torka P; Wilcox R; William B; Zain J; Dwyer MA; Sundar H
J Natl Compr Canc Netw; 2018 Feb; 16(2):123-135. PubMed ID: 29439173
[TBL] [Abstract][Full Text] [Related]
7. T-cell lymphomas, a challenging disease: types, treatments, and future.
Ma H; Abdul-Hay M
Int J Clin Oncol; 2017 Feb; 22(1):18-51. PubMed ID: 27743148
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances of nasal natural killer/T-cell lymphoma].
Liu Y; Yang HY; Lu MZ
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):809-12. PubMed ID: 16545194
[No Abstract] [Full Text] [Related]
9. Natural killer/T-cell lymphomas in pediatric and adolescent patients.
Termuhlen AM
Clin Adv Hematol Oncol; 2017 Mar; 15(3):200-209. PubMed ID: 28398275
[TBL] [Abstract][Full Text] [Related]
10. Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.
Sandlund JT; Perkins SL
Br J Haematol; 2015 Jun; 169(5):631-46. PubMed ID: 25851546
[TBL] [Abstract][Full Text] [Related]
11. NK/T-cell lymphoma, nasal type, γδ T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment.
Geller S; Myskowski PL; Pulitzer M
Semin Cutan Med Surg; 2018 Mar; 37(1):30-38. PubMed ID: 29719018
[TBL] [Abstract][Full Text] [Related]
12. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
13. Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines.
Iwatsuki K; Hamada T;
J Dermatol; 2014 Jan; 41(1):43-9. PubMed ID: 24438144
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
Cheung MM; Chan JK; Wong KF
Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
[TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms.
Shi Y; Wang E
Arch Pathol Lab Med; 2015 Sep; 139(9):1173-80. PubMed ID: 26317456
[TBL] [Abstract][Full Text] [Related]
16. Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Staber PB; Herling M; Bellido M; Jacobsen ED; Davids MS; Kadia TM; Shustov A; Tournilhac O; Bachy E; Zaja F; Porkka K; Hoermann G; Simonitsch-Klupp I; Haferlach C; Kubicek S; Mayerhoefer ME; Hopfinger G; Jaeger U; Dearden C
Blood; 2019 Oct; 134(14):1132-1143. PubMed ID: 31292114
[TBL] [Abstract][Full Text] [Related]
17. Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas.
Chan JY; Lim ST
Int J Hematol; 2018 Apr; 107(4):413-419. PubMed ID: 29380182
[TBL] [Abstract][Full Text] [Related]
18. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
Kwong YL; Anderson BO; Advani R; Kim WS; Levine AM; Lim ST;
Lancet Oncol; 2009 Nov; 10(11):1093-101. PubMed ID: 19880063
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
[TBL] [Abstract][Full Text] [Related]
20. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
Tse E; Kwong YL
Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
